Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice
Abstract Plasma xanthine oxidoreductase (XOR) activity is high in metabolic disorders such as diabetic mellitus, obesity, or overweight. Thus, this study investigated whether the XOR inhibitor, topiroxostat, affected body weight. Male db/db mice were fed standard diets with or without topiroxostat f...
Main Authors: | Takashi Nakamura, Mai Nampei, Takayo Murase, Etsuko Satoh, Seigo Akari, Noriaki Katoh, Hiroki Mizukami |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Nutrition & Diabetes |
Online Access: | https://doi.org/10.1038/s41387-021-00155-2 |
Similar Items
-
Xanthine oxidoreductase inhibitor topiroxostat ameliorates podocyte injury by inhibiting the reduction of nephrin and podoplanin
by: Ying Zhang, et al.
Published: (2021-09-01) -
Inhibitory effects of xanthine oxidase inhibitor, topiroxostat, on development of neuropathy in db/db mice
by: Kazuhisa Takahashi, et al.
Published: (2021-07-01) -
Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment
by: Yusuke Kawachi, et al.
Published: (2021-08-01) -
Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
by: Masato Furuhashi, et al.
Published: (2019-07-01) -
Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction
by: Ken Watanabe, et al.
Published: (2020-08-01)